Osteosarcoma in Patients with Rothmund–Thomson Syndrome

REFERENCES

• Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis. 2010;5:2.
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Wakamatsu E, Yosizawa Z. Increased excretion of urinary gylcosaminoglycans in a case of Rothmund Thomson syndrome. Tohoku J exp Med. 1978;126:1–6.
   Google Scholar
• Enneking WF, Kagan A. “Skip” metastases in osteosarcoma. Cancer. 1975;36:2192–2205.
   PubMedGoogle Scholar
• Enneking WF, Kagan A. The implications of “skip” metastases in osteosarcoma. Clin Orthop Relat Res. 1975;111:33–41.
   Google Scholar
• Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd. 2001;149:807–818.
   Web of Science ®Google Scholar
• Bielack S, Juergens H, Jundt G, et al. Osteosarcoma: the COSS experience. Cancer Treat Res. 2009;152:289–308.
   PubMedGoogle Scholar
• Bielack S, Kempf-Bi, elack B, Schwenzer D, et al. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]. Klin Padiatr. 1999;211:260–270.
   PubMedGoogle Scholar
• Winkler K, Beron G, Kotz R, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol. 1984;2:617–624.
   PubMed Web of Science ®Google Scholar
• Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988;6:329–337.
   PubMed Web of Science ®Google Scholar
• Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998;9:893–899.
   PubMed Web of Science ®Google Scholar
• Salzer-Kuntschik M, Delling G, Beron G, et al. Morphological grades of regression in osteosarcoma after polychemotherapy—study COSS 80. J Cancer Res Clin Oncol. 1983;106 Suppl:21–24.
   PubMed Web of Science ®Google Scholar
• Kaplan EL MP. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.
   Web of Science ®Google Scholar
• Simon T, Kohlhase J, Wilhelm C, et al. Multiple malignant diseases in a patient with Rothmund-Thomson Syndrome with RECQL4 mutations: case report and literature review. Am J Med Genet A. 2010;152A:1575–1579.
   PubMed Web of Science ®Google Scholar
• Kirchner J, Schmidt H, Hoerlin A. Rothmund-Thomson syndrome and osteosarcoma. Roentgenpraxis. 1999;52:71–73.
   Google Scholar
• Enneking WF, Soanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–120.
   PubMed Web of Science ®Google Scholar
• Stinco G, Governatori G, Mattighello P, et al. Multiple cutaneus neoplasms in a patient with Rothmund-Thomson syndrome: case report and published work-review. J Dermatol. 2008;35:154–161.
   Google Scholar
• Carlson AM, Lindor NM, Litzow MR. Therapy-related myelodysplasia in a patient with Rothmund-Thomson syndrome. Eur J Haematol. 2011;86:536–540.
   Google Scholar
• Padhy D, Madhuri V, Pulimood SA, et al. Metatarsal osteosarcoma in Rothmund-Thomson syndrome: a case report. J Bone Joint Surg Am. 2010;92:726–730.
   Google Scholar
• Cabral RE, Queille S, Bodemer C, et al. Identification of new RECQL4 mutations in Caucasian Rothmund-Thomson patients and analysis of sensitivity to a wide range of genotoxic agents. Mutat Res. 2008;643:41–47.
   Google Scholar
• Hicks MJ, Roth JR, Kozinetz C, et al. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. J Clin Oncol. 2007;25:370–375.
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol. 2002;20:776–790.
   PubMed Web of Science ®Google Scholar
• Whelan JS, Jinks RC, McTiernan A, et al. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol. 2012;6:1607–1616.
   Google Scholar
• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531–1543.
   PubMed Web of Science ®Google Scholar
• Sim FH, DeVries EMG, Miser JS, et al. Case report 760. Skeletal Radiol. 1992;21:543–545.
   Google Scholar
• Lindor NM, Devries EMG, Michels VV, et al. Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism. Clin Gent. 1996;49:124–129.
   Google Scholar
• Judge MR, Kilby A, Harper JI. Rothmund-Thomson syndrome and osteosarcoma. Br J Dermatol. 1993;129:723–725.
   Google Scholar
• Leonard A, Craft AW, Moss C, et al. Osteogenic sarcoma in the Rothmund-Thomson syndrome. Med Pediatr Oncol. 1996;26:249–253.
   Google Scholar